ReviewAmerican journal of translational research2025
Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: research progress.
Review in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between neutrophil-to-lymphocyte ratio and the prognosis of patients with rheumatoid arthritis: a meta-analysis.Frontiers in immunology · 2026Pooled it
- The merits of the prognostic nutritional index and neutrophil-to-lymphocyte ratio in predicting outcomes of coronary artery bypass grafting: a retrospective cohort study.BMC cardiovascular disorders · 2026Article
- Association of the Naples prognostic score with all-cause and cardiovascular mortality in U.S. patients with heart failure: a retrospective cohort study using NHANES 2001-2018.Journal of health, population, and nutrition · 2026Article
- Biomarkers in Heart Failure: A Review and a Wish.International journal of molecular sciences · 2025Review
- Fibrosis-4 index as a predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease.PloS one · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The neutrophil to lymphocyte ratio (NLR) is a simple, reliable, and easily accessible composite index that has garnered increasing attention in cardiovascular research. NLR is closely associated with the onset, progression, and prognosis of various cardiovascular diseases. This article reviews the etiological and prognostic roles of NLR in cardiovascular conditions such as coronary atherosclerotic heart disease, hypertension, arrhythmia, heart failure, and valvular heart disease. Studies have shown that NLR is involved in the pathophysiologic processes of these diseases and holds significant predictive value for their prognosis. Additionally, compared to other inflammatory markers, NLR offers advantages such as low cost, repeatability, and the ability to be measured at the community-level primary healthcare settings, thus providing new insight for prognostic prediction in conditions like coronary artery disease, arrhythmia, hypertension, heart failure, and valvular heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.